Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1266818.RAp57_Xntsdnn0ckzKo7_AK0cQrctLXinISX3838ZltwA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1266818.RAp57_Xntsdnn0ckzKo7_AK0cQrctLXinISX3838ZltwA130_assertion type Assertion NP1266818.RAp57_Xntsdnn0ckzKo7_AK0cQrctLXinISX3838ZltwA130_head.
- NP1266818.RAp57_Xntsdnn0ckzKo7_AK0cQrctLXinISX3838ZltwA130_assertion description "[First the BE(2)-M17 cell line has been used as a model for APP metabolism studies and next, SH-SY5Y-TMHT441 cells were used for AD drugs screening targeting tau phosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266818.RAp57_Xntsdnn0ckzKo7_AK0cQrctLXinISX3838ZltwA130_provenance.
- NP1266818.RAp57_Xntsdnn0ckzKo7_AK0cQrctLXinISX3838ZltwA130_assertion evidence source_evidence_literature NP1266818.RAp57_Xntsdnn0ckzKo7_AK0cQrctLXinISX3838ZltwA130_provenance.
- NP1266818.RAp57_Xntsdnn0ckzKo7_AK0cQrctLXinISX3838ZltwA130_assertion SIO_000772 25724081 NP1266818.RAp57_Xntsdnn0ckzKo7_AK0cQrctLXinISX3838ZltwA130_provenance.
- NP1266818.RAp57_Xntsdnn0ckzKo7_AK0cQrctLXinISX3838ZltwA130_assertion wasDerivedFrom befree-2016 NP1266818.RAp57_Xntsdnn0ckzKo7_AK0cQrctLXinISX3838ZltwA130_provenance.
- NP1266818.RAp57_Xntsdnn0ckzKo7_AK0cQrctLXinISX3838ZltwA130_assertion wasGeneratedBy ECO_0000203 NP1266818.RAp57_Xntsdnn0ckzKo7_AK0cQrctLXinISX3838ZltwA130_provenance.